Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(22%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_1
3
33%
Ph phase_2
1
11%
Ph early_phase_1
1
11%
Ph phase_3
2
22%
Ph phase_4
2
22%

Phase Distribution

4

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Active, not recruiting1
Withdrawn1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 13 (33.3%)
Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 42 (22.2%)

Trials by Status

active_not_recruiting111%
withdrawn111%
completed556%
unknown111%
recruiting111%

Recent Activity

2 active trials
Showing 5 of 9
completedphase_4

Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

NCT05514002
active_not_recruitingphase_4

Opioid, HIV and Immune System

NCT04304768
withdrawnphase_1

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

NCT06229392
recruitingearly_phase_1

Intradermal Influenza Vaccination

NCT06067555
completedphase_1

Effects of Aging on Primary and Secondary Vaccine Responses

NCT03312699
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05514002Phase 4

Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Completed
NCT04304768Phase 4

Opioid, HIV and Immune System

Active Not Recruiting
NCT06229392Phase 1

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Withdrawn
NCT06067555Early Phase 1

Intradermal Influenza Vaccination

Recruiting
NCT03312699Phase 1

Effects of Aging on Primary and Secondary Vaccine Responses

Completed
NCT04120194Phase 3

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Completed
NCT03926416Phase 1

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Completed
NCT02242643Phase 3

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

Completed
NCT02434276Phase 2

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Unknown

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9